Watchlist Price Alert

Ensysce Biosciences Inc. (ENSC)

NASDAQ: ENSC · Real-Time Price · USD

2.60

-0.37 (-12.46%)

At close: May 02, 2025, 3:59 PM

2.60

-0.14%

After-hours: May 02, 2025, 05:52 PM EDT

Ensysce Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	3.5M	1.12M	3.15M	12.26M	194.21K	1.06M	1.66M	2.09M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	195.31M	202.92M	200.12M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	195.31M	202.92M	200.12M
Other Long-Term Assets	252.55K	419.22K	558.72K	-24.72B	3.78K	-351	-1	n/a
Receivables	124.11K	97.56K	276.82K	441.72K	n/a	n/a	170.53K	n/a
Inventory	n/a	n/a	-276.82K	-441.72K	n/a	1.00	n/a	n/a
Other Current Assets	18K	18K	1.33M	2.15M	23.54K	n/a	n/a	n/a
Total Current Assets	5.34M	2.29M	5.3M	15.66M	347.88K	1.2M	1.92M	2.31M
Property-Plant & Equipment	n/a	n/a	27.16K	24.72B	151.00	351.00	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	252.55K	419.22K	585.88K	754.76K	3.93K	195.31M	202.92M	200.12M
Total Assets	5.6M	2.71M	5.89M	16.42M	351.81K	196.51M	204.83M	202.43M
Account Payables	1.36M	1.94M	2.94M	301.1K	1.72M	540.78K	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	159.05K	-3.16M	n/a	n/a
Short-Term Debt	301.66K	854.7K	4.27M	12.75M	4.25M	n/a	n/a	n/a
Other Current Liabilities	548.46K	n/a	n/a	n/a	670.26K	1.02M	437.89K	152.6K
Total Current Liabilities	2.21M	3.33M	9.46M	16.48M	7.01M	2.77M	437.89K	156.24K
Long-Term Debt	n/a	n/a	140.15K	4.44M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	10.1K	26.39K	310.35K	3.65M	n/a	7.57M	n/a	n/a
Total Long-Term Liabilities	10.1K	26.39K	450.49K	8.09M	6.75M	7.57M	7M	7M
Total Liabilities	2.22M	3.36M	9.91M	24.58M	7.01M	10.34M	7.44M	7.16M
Total Debt	301.66K	854.7K	4.41M	12.75M	4.27M	566.27K	n/a	n/a
Common Stock	136.00	315.00	642.00	2.46K	1.58K	181.18M	604.00	673.00
Retained Earnings	-129,544.3B	-121.56M	-110.93M	-85.85M	-55.96M	2.46M	2.09M	-31.19K
Comprehensive Income	n/a	n/a	n/a	n/a	0.00	0.00	-604	-673
Shareholders Equity	3,708.4B	-322.86K	-4.03M	-8.16M	-6.44M	186.17M	197.39M	195.27M
Total Investments	3,502.1B	n/a	n/a	n/a	n/a	195.31M	202.92M	200.12M